RetractedArticleEvidence-based complementary and alternative medicine : eCAM2022

Evaluation of lncRNA FOXD3-AS1 as a Biomarker for Early-Stage Lung Cancer Diagnosis and Subtype Identification.

Xiaofeng Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.